Home
Institutions
Filings
Issuers
About
All
Index / Passive
Hedge Fund
VC / PE / Holdco
Long-Term Concentrated
Concentrated Active
Quant / Systematic
Diversified Active
BIOCRYST PHARMACEUTICALS INC
Ticker: BCRX
CUSIP: 09058V103
Class: Common Stock
Stephens Consulting, LLC's Holding History (CIK: 0001961632)
Note: Option positions (PUT/CALL) are excluded.
Q1 2025
Shares
50
Value ($000)
$0
Avg Close
$8.07
Range
$6.96 - $9.50
Period
Shares
Value ($000)
Average Close
Price Range
Q1 2025
50
$0
$8.07
$6.96 - $9.50